ACI - Foreign Patent Law & Regulation

This event has been designed to provide in-house patent and IP counsel within the pharmaceutical, biopharmaceutical, biotechnology and medical device industries with a working knowledge of the current status of patent law in key foreign jurisdictions. A leading faculty comprised of experienced in-house counsel representing such multi-national companies as: Boehringer Ingelheim, GlaxoSmithKline, Medtronic, Novartis, Novo Nordisk, Purdue Pharma, Sanofi-Aventis, Sanofi Pasteur, Schering-Plough, as well as patent prosecution attorneys and litigation counsel from: Australia, Belgium, China, India, Germany, Japan, Korea, Netherlands, Switzerland and the United Kingdom will provide you with an in-depth overview of the unique issues that arise in the context of both prosecution and litigation outside the U.S.

Attend this event and enhance your understanding of the nuances of foreign patent prosecution and litigation that specifically apply to the life sciences industry.

Teresa Rea is co-chair of this event. Jan-Diederik Lindemans is speaking on "Understanding The Mechanics of Conducting and Seeking Discovery in Foreign Jurisdictions."

Janet MacLeod will also attend this event.